Geri-PARDY! (2015 Beers Criteria) Pharmacology Edition

Size: px
Start display at page:

Download "Geri-PARDY! (2015 Beers Criteria) Pharmacology Edition"

Transcription

1 Geri-PARDY! Pharmacology Edition (2015 Beers Criteria) Aurelio Muyot, MD, AGSF, FACP Assistant Professor College of Osteopathic Medicine Touro University Nevada

2 Objectives Review the 2015 Beers Criteria for Potentially Inappropriate Medications (PIM) What s new in 2015 Criteria How to use it to choose the appropriate medication(s)

3 Beers Criteria or as we know it Beers List History First list of potentially inappropriate medications was developed in 1991 for nursing home residents Revisions in 1997 and 2003 now includes all setting of geriatric care Update in 2012 was now under the auspices of the American Geriatrics Society Most recent update was in 2015

4 American Geriatrics Society 2015 Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults. J Am Geriatr Soc. 63(11), Nov 2015,

5 What s New in the 2015 Criteria 1. Drug classes A. Anti-arrhythmics in atrial fibrillation Can be used as first line now with some caveats Example: Recommends to avoid disopyramide due to anticholinergic side effects B. Avoid proton pump inhibitors use beyond 8 weeks due to association with C. difficile infection, bone loss, and fractures C. Avoid non-benzodiazepine, benzodiazepine receptor agonist hypnotics due to minimal efficacy in insomnia and potential for harm

6 What s New in the 2015 Criteria 2. Drugs and disease/syndromes A. Avoid non-benzodiazepine, benzodiazepine receptor agonist hypnotics in patient with dementia/cognitive impairment B. Avoid opioids in patients with a history of falls or fractures C. Avoid anti-psychotics as first-line treatment for delirium

7 What s New in the 2015 Criteria 3. Specific drugs A. Nitrofurantoin can be used in patients with CrCl 30 ml/min. (previously 60 ml/min.), but long term use is not recommended due to toxicity B. Avoid desmopressin as treatment for nocturia/nocturnal polyuria due to high risk of hyponatremia

8 What s New in the 2015 Criteria 4. Addition of Drug-Drug Interactions Category Taking 3 or more CNS-active drugs ACE and K sparing diuretics 5. Addition of Dose Adjustment based on kidney function Direct-acting oral anticoagulants (DOAC) H2 blockers Uric acid lowering agents

9 How to Use the Guide

10 Applying the 2015 Beers Criteria Think of the AGS 2015 Beers Criteria as a warning light that should prompt close review and monitoring of the medication. Medications are listed as potentially inappropriate, not definitely inappropriate There are caveats to the recommendations and rationale, as well as guidance Recommendations may not be applicable to all sites or clinical situations

11 Potentially Inappropriate Medication Drugs to avoid with this disease Proceed with Caution Drug-Drug Interactions Kidney Function and Drugs Anti- Cholinergic Drugs

12 100 The largest medical school in Nevada What is the College of Osteopathic Medicine at Touro University Nevada?

13 Potentially Inappropriate Medication Drugs to avoid with this disease Proceed with Caution Drug-Drug Interactions Kidney Function and Drugs Anti- Cholinergic Drugs

14 100 Drug often found in over the counter (OTC) sleep aids What is diphenhydramine?

15 First Generation Anti-histamines and Older Patients Clearance is reduced with advanced age Tolerance develops when used a hypnotic Anti-cholinergic side effects Confusion Dry mouth Constipation, etc. Diphenhydramine may be appropriate as treatment for acute allergic reaction

16 200 Class of anti-hypertensives associated with a high risk of CNS side effects What are central alpha blockers? Other side effects include bradycardia, orthostatic hypotension

17 300 Older anti-thrombotic not recommended in oral-short acting form What is dipyridamole? May cause orthostatic hypotension

18 400 Anti-parkisonian agent with significant anti-cholinergic side effects What is trihexyphenidyl?

19 500 Antibiotic for urinary infection not recommended for long term use What is nitrofurantoin? Potential for pulmonary toxicity, hepatotoxicity, and peripheral neuropathy

20 100 GI motility drug to avoid with Parkinson disease What is metoclopramide?

21 200 Analgesic class to avoid in heart failure patient What are NSAID or COX-2 inhibitors?

22 300 Drug class associated with increased risk of stroke and mortality in persons with dementia What are antipsychotics?

23 Dementia-related Behavioral Problems Look for triggers Physiologic Environmental Medical or psychologic Non-pharmacologic interventions should be attempted first Pharmacologic treatment only if nonpharmacologic measures have failed and older adult is threatening harm to self or others

24 400 True or False: Nonbenzodiazepine hypnotics are safer to use in older persons who fall vs. benzodiazepines What is False? Can cause ataxia, impaired psychomotor function, syncope, additional falls

25 500 Oral and transdermal forms not recommended in women with urinary incontinence What is estrogen? Aggravates incontinence. Intravaginal estrogen may help with GU symptoms.

26 100 Commonly recommended OTC for primary prevention of CV events What is aspirin? Lack of evidence of benefit vs. risk in adults 80

27 200 Direct oral anticoagulant with antidote, use with caution in adults 75 or CrCl < 30 ml/min. What is dabigatran?

28 300 Anti-seizure medication that may cause or exacerbate SIADH What is carbamazepine or oxcarbazepine? Also has an antidiuretic effect

29 400 Antidepressant classes associated with SIADH (name at least 2/3) What are SSRIs, SNRIs, or TCAs?

30 500 What electrolyte should you monitor when your patient is on an antipsychotic? What is sodium? Thought to be due to either stimulating ADH release or by enhancing activity of ADH in the kidneys

31 100 Electrolyte abnormality risk when combining ACEI and triamterene What is hyperkalemia?

32 200 Risk of this geriatric syndrome increases when combining zoldipem with 2 CNS-active drugs What is falls? Also increases fracture risk.

33 300 CNS side effect when combining meclizine with oxybutynin What is cognitive decline? Both are anti-cholinergic.

34 400 Urinary side effect in women when combining alpha-1 blocker and loop diuretic What is urinary incontinence?

35 500 Increased risk of this side effect when combining warfarin with amiodarone What is bleeding? Amiodarone inhibits the enzymes that metabolize warfarin

36 100 Non-mineralocorticoid diuretic to avoid when CrCl <30 ml/min. due to hyperkalemia risk What is/are triamterene and amiloride?

37 200 Uric acid lowering drug that is no longer effective when CrCl 30 ml/min. What is probenecid?

38 300 Reduction of dose recommended with this class of GI medication when CrCl <50 ml/min. What are H2 blockers? Can cause mental status changes.

39 400 Avoid this adjuvant medication for chronic pain when CrCl < 30 ml/min. What is duloxetine? Increases GI side effects.

40 500 Direct oral thrombin inhibitor to avoid when CrCl <30 ml/min. What is dabigatran?

41 100 Antiarrhythmic with strong anticholinergic property What is disopyramide?

42 200 OTC sleep medication with strong anticholinergic property What is diphenhydramine?

43 300 Antidepressant class with strong anticholinergic properties What are tricyclics?

44 400 Antiemetic with strong anticholinergic property What is prochloroperazine or promethazine?

45 500 Muscle relaxant (s) with strong anticholinergic properties What is cyclobenzaprine or orphenadine?

46

47 Category: Person

48 Who s picture is this?

49 Who is Dr. Mark Beers?

50 Questions?

1/21/2016 UPDATE ON THE AMERICAN GERIATRICS SOCIETY 2015 BEERS CRITERIA DISCLOSURE OBJECTIVES AGING GOALS BEERS CRITERIA

1/21/2016 UPDATE ON THE AMERICAN GERIATRICS SOCIETY 2015 BEERS CRITERIA DISCLOSURE OBJECTIVES AGING GOALS BEERS CRITERIA UPDATE ON THE AMERICAN GERIATRICS SOCIETY 2015 BEERS CRITERIA DISCLOSURE I have no financial conflict of interest to disclose. Lacey Charbonneau, Pharm.D. PGY-1 Community Practice Resident Baptist Medical

More information

COMMON DRUG RELATED PROBLEMS SEEN IN PACE AND MECHANISMS TO MITIGATE RISK

COMMON DRUG RELATED PROBLEMS SEEN IN PACE AND MECHANISMS TO MITIGATE RISK COMMON DRUG RELATED PROBLEMS SEEN IN PACE AND MECHANISMS TO MITIGATE RISK Robert L Alesiani, PharmD, CGP Chief Pharmacotherapy Officer CareKinesis, Inc. (a Tabula Rasa Healthcare Company) 2 3 4 5 Pharmacogenomics

More information

Maximizing Medication Safety UNIVERSITY OF HAWAII AUGUST 31, 2016

Maximizing Medication Safety UNIVERSITY OF HAWAII AUGUST 31, 2016 Maximizing Medication Safety UNIVERSITY OF HAWAII AUGUST 31, 2016 Adverse Drug Events (ADE s) RISK FACTORS FOR Adverse Drug Events (ADEs) 6 or more concurrent chronic conditions 12 or more doses of drugs/day

More information

American Geriatrics Society 2015 Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults

American Geriatrics Society 2015 Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults CLINICAL INVESTIGATIONS American Geriatrics Society 2015 Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults By the American Geriatrics Society 2015 Beers Criteria Update

More information

Medication Use in Older Adults

Medication Use in Older Adults Medication Use in Older Adults F. Michael Gloth, III, MD, AGSF, FACP, CMD Clinical Professor Department of Geriatrics, Florida State University College of Medicine Associate Professor of Medicine Division

More information

Pennsylvania Academy of Family Physicians Foundation & UPMC 43rd Refresher Course in Family Medicine CME Conference March 10-13, 2016

Pennsylvania Academy of Family Physicians Foundation & UPMC 43rd Refresher Course in Family Medicine CME Conference March 10-13, 2016 Pennsylvania Academy of Family Physicians Foundation & UPMC 43rd Refresher Course in Family Medicine CME Conference March 10-13, 2016 Disclosures: Drugs in Older Adults: Beers Criteria Heather Sakely,

More information

Medication Assessment and Quality Parameters. Norma J. Owens, PharmD, FCCP Professor of Pharmacy University of Rhode Island

Medication Assessment and Quality Parameters. Norma J. Owens, PharmD, FCCP Professor of Pharmacy University of Rhode Island Medication Assessment and Quality Parameters Norma J. Owens, PharmD, FCCP Professor of Pharmacy University of Rhode Island Financial Disclosure None of the planners, speakers, and/or members of the CME

More information

Katee Kindler, PharmD, BCACP

Katee Kindler, PharmD, BCACP Speaker Introduction Katee Kindler, PharmD, BCACP Current Practice: Clinical Pharmacy Specialist Ambulatory Care, St. Vincent Indianapolis Assistant Professor of Pharmacy Practice, Manchester University,

More information

Objectives. What are the Beers Criteria? Mark H Beers, MD Beers Criteria: History and Utilization 5/24/2016

Objectives. What are the Beers Criteria? Mark H Beers, MD Beers Criteria: History and Utilization 5/24/2016 @agilis Objectives Understand what the AGS Beer s list is and the methods used for the AGS Beer s Update HOW TO USE THE BEERS CRITERIA IN PERSONS WITH DEMENTIA & IN YOUR HEALTHCARE SYSTEM DONNA FICK, RN,

More information

AGS. From THE AMERICAN GERIATRICS SOCIETY AGS 2015 BEERS CRITERIA

AGS. From THE AMERICAN GERIATRICS SOCIETY AGS 2015 BEERS CRITERIA From THE AMERICAN GERIATRICS SOCIETY AGS 2015 BEERS CRITERIA This guide has been developed as a tool to assist healthcare providers in improving medication safety in older adults. The role of this guide

More information

Use of diphenhydramine in situations such as acute treatment of. treatment of Parkinson disease. Avoid

Use of diphenhydramine in situations such as acute treatment of. treatment of Parkinson disease. Avoid From THE AMERICAN GERIATRICS SOCIETY A POCKET GUIDE TO THE AGS 2015 BEERS CRITERIA This guide has been developed as a tool to assist healthcare providers in improving medication safety in older adults.

More information

STOPP START Toolkit Supporting Medication Review in the Older Person

STOPP START Toolkit Supporting Medication Review in the Older Person STOPP START Toolkit Supporting Medication Review in the Older Person STOPP: Screening Tool of Older People s potentially inappropriate Prescriptions START: Screening Tool to Alert doctors to Right (appropriate,

More information

STOPP and START criteria October 2011

STOPP and START criteria October 2011 # START and STOPP are newer criteria to identify potentially inappropriate medications in elderly, including drug drug and drug disease interactions, drugs which increase risk of falls and drugs which

More information

Fall Prevention in Hospice (A pharmacologic and nonpharmacologic approach)

Fall Prevention in Hospice (A pharmacologic and nonpharmacologic approach) Fall Prevention in Hospice (A pharmacologic and nonpharmacologic approach) Chinenye Emereole, Pharm.D. Clinical Pharmacist Hospice Pharmacy Solutions Objectives Assess and identify hospice patients who

More information

Geriatric Pharmacology

Geriatric Pharmacology Geriatric Pharmacology Janice Scheufler R.Ph.,PharmD, FASCP Clinical Pharmacist Hospice of the Western Reserve Objectives List three risk factors for adverse drug events in the elderly Discuss two physiological

More information

Deconstructing Polypharmacy. Alan B. Douglass, M.D. Director

Deconstructing Polypharmacy. Alan B. Douglass, M.D. Director Deconstructing Polypharmacy Alan B. Douglass, M.D. Director Recognize this patient? Mrs. Brown- 82 years young Active Medical Problems Hypertension Hyperlipidemia Type 2 Diabetes Peripheral edema Osteoarthritis

More information

Inappropriate Medication Use in the Elderly

Inappropriate Medication Use in the Elderly Inappropriate Medication Use in the Elderly Amanda Ilenin, Pharm.D. OhioHealth Dublin Methodist Hospital & OhioHealth Grady Memorial Hospital Kristian Navickas, Pharm.D. OhioHealth McConnell Heart Health

More information

Geriatric Pharmacology. Kwi Bulow, M.D. Clinical Professor of Medicine Director, Academic Geriatric Resource Center

Geriatric Pharmacology. Kwi Bulow, M.D. Clinical Professor of Medicine Director, Academic Geriatric Resource Center Geriatric Pharmacology Kwi Bulow, M.D. Clinical Professor of Medicine Director, Academic Geriatric Resource Center Silver Tsunami 2010: 40 million (13%) 2030: 72 million (20%) Baby Boomers (1946-1964)

More information

Pharmaceutical Care for Geriatrics

Pharmaceutical Care for Geriatrics Continuing Professional Pharmacy Development Program Pharmaceutical Care for Geriatrics Presented by: Alla El-Awaisi; MPharm, MRPharmS, MSc Event Organizer: Dr. Nadir Kheir; PhD Disclaimer: PRESENTING

More information

Geriatric Polypharmacy: A Pill for Every ill? Speaker has no relationship to disclose. Objectives. Amelie Hollier, DNP, FNP BC, FAANP President, APEA

Geriatric Polypharmacy: A Pill for Every ill? Speaker has no relationship to disclose. Objectives. Amelie Hollier, DNP, FNP BC, FAANP President, APEA Geriatric Polypharmacy: A Pill for Every ill? Amelie Hollier, DNP, FNP BC, FAANP President, APEA Speaker has no relationship to disclose. Objectives 1. Assess medications for elder appropriateness prior

More information

Guideline Summary NGC-10857

Guideline Summary NGC-10857 Guideline Summary NGC-10857 Guideline Title American Geriatrics Society 2015 updated Beers Criteria for potentially inappropriate medication use in older adults. Bibliographic Source(s) American Geriatrics

More information

Falls most commonly seen in RACFs are due to tripping, slipping and stumbling (21.6%). Falling down stairs is relatively uncommon in

Falls most commonly seen in RACFs are due to tripping, slipping and stumbling (21.6%). Falling down stairs is relatively uncommon in This Presentation Medications and Falls Dr Peter Tenni M Pharm (Curtin), PhD (UTAS) AACPA Director, CPS A fall is an event which results in a person coming to rest inadvertently on the ground or floor

More information

American Geriatrics Society 2019 Updated AGS Beers Criteria for Potentially Inappropriate Medication Use in Older Adults

American Geriatrics Society 2019 Updated AGS Beers Criteria for Potentially Inappropriate Medication Use in Older Adults CLINICAL INVESTIGATION American Geriatrics Society 2019 Updated AGS Beers Criteria for Potentially Inappropriate Medication Use in Older Adults By the 2019 American Geriatrics Society Beers Criteria Update

More information

When Less is More: Managing Medication for Older Adults

When Less is More: Managing Medication for Older Adults When Less is More: Managing Medication for Older Adults Sunny Linnebur, PharmD, BCGP, BCPS Robert Page, PharmD, MSPH, BCGP, BCPS-AQ Cardiology Professors, University of Colorado Skaggs School of Pharmacy

More information

PRESCRIBING IN THE ELDERLY. CARE HOME PHARMACY TEAM Bhavini Shah, Eleesha Pentiah & Puja Vyas

PRESCRIBING IN THE ELDERLY. CARE HOME PHARMACY TEAM Bhavini Shah, Eleesha Pentiah & Puja Vyas PRESCRIBING IN THE ELDERLY CARE HOME PHARMACY TEAM Bhavini Shah, Eleesha Pentiah & Puja Vyas LEARNING OUTCOMES Medicines Optimisation The effects of aging on health and medicines. Polypharmacy Acute Kidney

More information

What s the Diagnosis?

What s the Diagnosis? Geriatric Polypharmacy: A Pill for Every Ill? Amelie Hollier, DNP, FNP-BC, FAANP President, APEA Fact # 1 Geriatric Patients US Life Expectancy Women: 81.0 years Men: 76.2 years http://www.cdc.gov/nchs/data/hus/hus13.pdf#018

More information

BEERs For the Elderly

BEERs For the Elderly BEERs For the Elderly February 2008 Presented by:carla Ambrosini Seniors First Clinic Pharmacist 12/05/2008 1 Objectives To highlight the overall health care impact of drug related adverse reactions and

More information

Medications Contributing to Falls. Kate Niemann, PharmD BCGP AuBurn Pharmacy

Medications Contributing to Falls. Kate Niemann, PharmD BCGP AuBurn Pharmacy Medications Contributing to Falls Kate Niemann, PharmD BCGP AuBurn Pharmacy Why Are Falls Important? Leading cause of injury in elders Costs to the system (CDC, 2008) ER Visits: 2.2 million $28.2 billion

More information

Antidepressants: Prof. Riyadh Al_Azzawi F.R.C.Psych

Antidepressants: Prof. Riyadh Al_Azzawi F.R.C.Psych Antidepressants: Prof. Riyadh Al_Azzawi F.R.C.Psych A. Heterocyclic antidepressants: (tricyclic and tetracyclic ), e.g.amitryptaline,imipramine. B. Monoamine oxidase inhibitors(m.a.o.i), e.g.phenelzine.

More information

Potentially Inappropriate Medication Use in Older Adults 2015 Latest Research

Potentially Inappropriate Medication Use in Older Adults 2015 Latest Research Home Resources Potentially Inappropriate Medication Use in Older Adults 2015 Resources Potentially Inappropriate Medication Use in Older Adults 2015 Latest Research Drugs and Categories of Drugs What these

More information

Anthony J. Caprio, MD, CMD, AGSF 1

Anthony J. Caprio, MD, CMD, AGSF 1 Objectives 1) Discuss the dangers of polypharmacy 2) Review potentially inappropriate medications for older adults Doc, I think I am taking too many medications! 3) Develop strategies for prioritizing

More information

PHARMACOTHERAPY IN THE OLDER PERSON NAMIRAH JAMSHED M.B;B.S ASSOCIATE PROFESSOR UTSW MEDICAL CENTER DALLAS

PHARMACOTHERAPY IN THE OLDER PERSON NAMIRAH JAMSHED M.B;B.S ASSOCIATE PROFESSOR UTSW MEDICAL CENTER DALLAS 1 PHARMACOTHERAPY IN THE OLDER PERSON NAMIRAH JAMSHED M.B;B.S ASSOCIATE PROFESSOR UTSW MEDICAL CENTER DALLAS OBJECTIVES 2 Know and understand: Key issues in geriatric pharmacology Effects of age on pharmacokinetics

More information

Polypharmacy. Polypharmacy. Suboptimal Prescribing in Older Adults. Kenneth Schmader, MD Professor of Medicine-Geriatrics

Polypharmacy. Polypharmacy. Suboptimal Prescribing in Older Adults. Kenneth Schmader, MD Professor of Medicine-Geriatrics Polypharmacy Kenneth Schmader, MD Professor of Medicine-Geriatrics Polypharmacy Definition Causes Consequences Prevention/management Suboptimal Prescribing in Older Adults Overuse Polypharmacy Underuse

More information

Using the ASCP-NCOA Falls Risk Reduction Toolkit Part 1: A Companion to CDC's STEADI Toolkit

Using the ASCP-NCOA Falls Risk Reduction Toolkit Part 1: A Companion to CDC's STEADI Toolkit Using the ASCP-NCOA Falls Risk Reduction Toolkit Part 1: A Companion to CDC's STEADI Toolkit Target Audience: Pharmacists ACPE#: 0202-9999-18-056-L01-P Activity Type: Application-based Disclosures Kathleen

More information

Nocdurna (desmopressin acetate) NEW PRODUCT SLIDESHOW

Nocdurna (desmopressin acetate) NEW PRODUCT SLIDESHOW Nocdurna (desmopressin acetate) NEW PRODUCT SLIDESHOW Introduction Brand name: Nocdurna Generic name: Desmopressin acetate Pharmacological class: Vasopressin (synthetic) Strength and Formulation: 27.7mcg,

More information

Appendix 3: Screening Tool of Older Persons Prescriptions (STOPP) version 2.

Appendix 3: Screening Tool of Older Persons Prescriptions (STOPP) version 2. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2 By Denis O'Mahony, David O'Sullivan, Stephen Byrne, Marie Noelle O'Connor, Cristin Ryan and Paul Gallagher Age

More information

Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults

Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults Dr. Janice Hoffman, PharmD, CGP, FASCP Dr. Sam Shimomura, PharmD, CGP, FASHP Western University of Health Sciences College

More information

American Geriatrics Society Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults

American Geriatrics Society Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults SPECIAL ARTICLES American Geriatrics Society Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults The American Geriatrics Society 2012 Beers Criteria Update Expert Panel

More information

Interface Prescribing Subgroup DRUGS FOR DEMENTIA: INFORMATION FOR PRIMARY CARE

Interface Prescribing Subgroup DRUGS FOR DEMENTIA: INFORMATION FOR PRIMARY CARE Cholinesterase inhibitors and Memantine are now classified as green (following specialist initiation) drugs by the Greater Manchester Medicines Management Group. Who will diagnose and decide who is suitable

More information

Workshop 4: Preventing Falls through Medication Vigilance

Workshop 4: Preventing Falls through Medication Vigilance Workshop 4: Preventing Falls through Medication Vigilance Nancy L. Losben, R.Ph., CCP, FASCP, CG Chief Quality Officer Omnicare, Inc. & Diane C. Vaughn, RN, C-DONA/LTC, LNHA VP, Clinical Services Benedictine

More information

AGS AGS 2015 BEERS CRITERIA. From THE AMERICAN GERIATRICS SOCIETY A POCKET GUIDE TO THE. PAGE 1 PAGE 2 Table 1 (continued on page 3)

AGS AGS 2015 BEERS CRITERIA. From THE AMERICAN GERIATRICS SOCIETY A POCKET GUIDE TO THE. PAGE 1 PAGE 2 Table 1 (continued on page 3) From THE AMERICAN GERIATRICS SOCIETY A POCKET GUIDE TO THE AGS 2015 BEERS CRITERIA This guide has been developed as a tool to assist healthcare providers in improving medication safety in older adults.

More information

Continuing Education

Continuing Education Continuing Education Guidelines Updates: Venous Thromboembolism, American Diabetes Association, Opioids, and Beers Criteria Authors: Katherine Fuller Pharm.D., 2016 Harrison School of Pharmacy, Auburn

More information

De-prescribing in Older Adults. Wael Hamade, MD, FAAFP 04/08/2016

De-prescribing in Older Adults. Wael Hamade, MD, FAAFP 04/08/2016 De-prescribing in Older Adults Wael Hamade, MD, FAAFP 04/08/2016 DISCLOSURES None of the faculty, planners, speakers, providers nor CME committee has any relevant financial relationships with commercial

More information

A Primer on Safe Prescribing to the Elderly. Dr. John Puxty

A Primer on Safe Prescribing to the Elderly. Dr. John Puxty A Primer on Safe Prescribing to the Elderly Dr. John Puxty Learning Objectives Describe an approach to safe prescribing for older patients. Appreciate the significance and causes of Polypharmacy. Identify

More information

Beers Criteria: Practical Considerations. A Clinician Education Tool. Curt Wood, RPh, CGP, FASCP

Beers Criteria: Practical Considerations. A Clinician Education Tool. Curt Wood, RPh, CGP, FASCP Beers Criteria: Practical Considerations A Clinician Education Tool Curt Wood, RPh, CGP, FASCP Objectives: u Explain the purpose of the Beers Criteria u Discuss the key concepts in applying the Beers Criteria

More information

Condition/Procedure Measure Compliance Criteria Reference Attribution Method

Condition/Procedure Measure Compliance Criteria Reference Attribution Method Premium Specialty: Cardiology Credentialed Specialties include: Cardiac Diagnostic, Cardiology, Cardiovascular Disease, Clinical Cardiac Electrophysiology, and Interventional Cardiology This document is

More information

OBJECTIVES. Key issues in geriatric pharmacology. Effects of age on pharmacokinetics and pharmacodynamics

OBJECTIVES. Key issues in geriatric pharmacology. Effects of age on pharmacokinetics and pharmacodynamics PHARMACOTHERAPY 1 OBJECTIVES 2 Know and understand: Key issues in geriatric pharmacology Effects of age on pharmacokinetics and pharmacodynamics Risk factors for adverse drug events for older patients

More information

Diabetes and the Elderly: Medication Considerations When Determining Benefits and Risks

Diabetes and the Elderly: Medication Considerations When Determining Benefits and Risks Diabetes and the Elderly: Medication Considerations When Determining Benefits and Risks Gretchen M. Ray, PharmD, PhC, BCACP, CDE Associate Professor UNM College of Pharmacy September 7 th, 2018 DISCLOSURES

More information

PA LTC Pharmacist s Role in Patient Safety and De-Prescribing

PA LTC Pharmacist s Role in Patient Safety and De-Prescribing PA LTC Pharmacist s Role in Patient Safety and De-Prescribing Nicole J. Brandt, PharmD, MBA, CGP, BCPP, FASCP Professor, Geriatric Pharmacotherapy, Pharmacy Practice and Science UMB School of Pharmacy

More information

NAVIGATING THE BEERS CRITERIA: BALANCING MEDICATION SAFETY AND EFFICACY IN THE GERIATRIC PATIENT KIMBERLY GRANT, PHARM.D.

NAVIGATING THE BEERS CRITERIA: BALANCING MEDICATION SAFETY AND EFFICACY IN THE GERIATRIC PATIENT KIMBERLY GRANT, PHARM.D. NAVIGATING THE BEERS CRITERIA: BALANCING MEDICATION SAFETY AND EFFICACY IN THE GERIATRIC PATIENT KIMBERLY GRANT, PHARM.D. DISCLOSURE STATEMENT I, the speaker, have no relative financial relationships to

More information

20.9 15.4 3.1 0.1 0.2 0.2 0.3 0.4 0.6 0.9 1.5 2.2 9.6 6.1 7.3 4.2 1900 1910 1920 1930 1940 1950 1960 1970 1980 1990 2000 2010 2020 2030 2040 2050 All Ages Age 65+ Age 85+ Female 50.9% Male 49.1% Female

More information

Reduction of High Risk Medications Using A Quality Initiative Perspective

Reduction of High Risk Medications Using A Quality Initiative Perspective Reduction of High Risk Medications Using A Quality Initiative Perspective Richard Mueller PharmD, MBA, MS, Director of Pharmacy Dianne Hempel BSN, RN Quality Improvement Coordinator Objectives Learn what

More information

Prevention of Medication-Related Falls Through Appropriate Medication Use. Clay Sprouse, MEd., CPhT Piedmont Technical College

Prevention of Medication-Related Falls Through Appropriate Medication Use. Clay Sprouse, MEd., CPhT Piedmont Technical College Prevention of Medication-Related Falls Through Appropriate Medication Use Clay Sprouse, MEd., CPhT Piedmont Technical College Disclosure I have no relevant financial or nonfinancial relationships to disclose

More information

Back to Basics: The Basics of Medication Monitoring

Back to Basics: The Basics of Medication Monitoring DIAMOND PHARMACY SERVICES Back to Basics: The Basics of Medication Monitoring Presented by: Dr. Deborah Milito, Pharm. D., CGP. Director of Clinical and Consultant Services Skilled Division Annual Educational

More information

1/24/2016. Continued. Objectives: Typical referral: 74 year old male with nausea/vomiting/diarrhea/weight loss

1/24/2016. Continued. Objectives: Typical referral: 74 year old male with nausea/vomiting/diarrhea/weight loss A typical day for the pharmacist without a pharmacy at the University of Utah Sugarhouse Clinic. Updates for Safe Medication Use in Older Adults Karen Gunning, Pharm.D, BCPS, BCACP, FCCP Professor and

More information

Polypharmacy. in the Elderly. Lesley Charles, MBChB, CCFP

Polypharmacy. in the Elderly. Lesley Charles, MBChB, CCFP Polypharmacy in the Elderly Lesley Charles, MBChB, CCFP Associate Professor and Program Director Division of Care of the Elderly Department of Family Medicine, University of Alberta March 06, 2016 1 Faculty/Presenter

More information

Updates to CMS SOM rules on Psychosocial Issues, Deficiency Categorization, and Psychotropic Medication Use

Updates to CMS SOM rules on Psychosocial Issues, Deficiency Categorization, and Psychotropic Medication Use Updates to CMS SOM rules on Psychosocial Issues, Deficiency Categorization, and Psychotropic Medication Use Stephen Eide R. Ph Oni Kinberg LCSW, MSSW Updates to the SOM On March 25, 2016 CMS sent out updates

More information

POLYPHARMACY IN OLDER ADULTS AND BEERS CRITERIA UPDATE

POLYPHARMACY IN OLDER ADULTS AND BEERS CRITERIA UPDATE POLYPHARMACY IN OLDER ADULTS AND BEERS CRITERIA UPDATE Jeannie Kim Lee, PharmD, BCPS, CGP Clinical Pharmacy Director College of Pharmacy The University of Arizona Learning Objectives: State the risks of

More information

Objectives. Polypharmacy and the Geriatric Patient: A Primer for the Orthopedic Nurse CONFLICT OF INTEREST

Objectives. Polypharmacy and the Geriatric Patient: A Primer for the Orthopedic Nurse CONFLICT OF INTEREST Polypharmacy and the Geriatric Patient: A Primer for the Orthopedic Nurse Presented by Eric Greenberg Pharm. D., CGP, BCPS, R.Ph. Clinical Pharmacist Hospital for Special Surgery CONFLICT OF INTEREST I

More information

Chitra Fernando, MD March 18, 2008

Chitra Fernando, MD March 18, 2008 Chitra Fernando, MD March 18, 2008 Definition Statistics Risk factors Why older adults are more prone to ADE Manifestations Inappropriate medications for older adults What can be done to minimize adverse

More information

Pitfalls in Pharmacotherapy of Geriatrics

Pitfalls in Pharmacotherapy of Geriatrics Pitfalls in Pharmacotherapy of Geriatrics DR Ali M. Alyami (M Pharm., PhD) Case Study An 85 year old female with a history of atrial fibrillation, stroke, dementia, and hypertension, who is receiving chronic

More information

Disclosures. Use caution in the elderly: review of safe and effective medication use in older patients. Institute of Medicine. Learning Objectives

Disclosures. Use caution in the elderly: review of safe and effective medication use in older patients. Institute of Medicine. Learning Objectives Use caution in the elderly: review of safe and effective medication use in older patients Disclosures I have no disclosures or conflicts of interest related to this presentation John T. Holmes, PharmD,

More information

Drug Interactions Year 2 Clinical Pharmacology

Drug Interactions Year 2 Clinical Pharmacology 1 Drug Interactions Year 2 Clinical Pharmacology Prof Mark McKeage Department of Pharmacology & Clinical Pharmacology 2 Objectives Explain the potential for interacting drugs to cause beneficial and harmful

More information

Psychotropic Medications: What s New?

Psychotropic Medications: What s New? Psychotropic Medications: What s New? Stacie L Penkova, PharmD, MHSA, BCPS Acclaim Pharmacy Benefits Manager Connected Care Partners Project Manager Outcomes Conference August 2016 Disclosures I, Stacie

More information

Deprescribing criteria based on NHS PrescQIPP/UKMI document Optimising Safe and Appropriate Medicines Use (OSAMU) [1]

Deprescribing criteria based on NHS PrescQIPP/UKMI document Optimising Safe and Appropriate Medicines Use (OSAMU) [1] Supplementary material for the paper The potential for deprescribing in care home residents with type 2 diabetes, by authors Lillan Mo Andreassen, Reidun Lisbet Skeide Kjome, Una Ørvim Sølvik, Julie Houghton,

More information

3/1/2018. Disclosures. Objectives. Clinical advisory board member- Daiichi Sankyo

3/1/2018. Disclosures. Objectives. Clinical advisory board member- Daiichi Sankyo Adjuvant pain medications in geriatrics Thomas B. Gregory, Pharm.D., BCPS, CPE, FASPE Clinical Pharmacy Specialist Pain Management CoxHealth Springfield, MO Disclosures Clinical advisory board member-

More information

University of Hawaii Center on Aging

University of Hawaii Center on Aging University of Hawaii Center on Aging. Supported in part by a cooperative agreement No. 90AL0011-01-00 from the Administration on Aging, Administration for Community Living, U.S. Department of Health and

More information

Update On The Latest Issues In Senior Health. Latest Issues In Senior Health:

Update On The Latest Issues In Senior Health. Latest Issues In Senior Health: Update On The Latest Issues In Senior Health Primary Care Conference 2016: LECOM Health LIGHT James Lin, DO, MHSA, MS(MedEd) VP Senior Services & Adult Living Director, LECOM Institute for Successful Aging

More information

GERIATRIC PHARMACOLOGY: A LOOK AT BEERS CRITERIA NATALIE R. BAKER, DNP, GNP-BC, ANP-BC. Disclaimer

GERIATRIC PHARMACOLOGY: A LOOK AT BEERS CRITERIA NATALIE R. BAKER, DNP, GNP-BC, ANP-BC. Disclaimer GERIATRIC PHARMACOLOGY: A LOOK AT BEERS CRITERIA NATALIE R. BAKER, DNP, GNP-BC, ANP-BC Disclaimer Majority of educational slides obtained from American Geriatrics Society http://teachingslides.americangeriatrics.org/sample.

More information

Definition and Statistics

Definition and Statistics Objectives 1. Describe the basic principles of how drugs work in the body and with one another. Nanette R Wrobel, RPh Director of Education/Clinical Director Pharmacy Alternatives 2. Identify the four

More information

Survey of Potentially Inappropriate Prescription Using STOPP/START Criteria in Inha University Hospital

Survey of Potentially Inappropriate Prescription Using STOPP/START Criteria in Inha University Hospital Korean J Fam Med. 2013;34:319-326 http://dx.doi.org/10.4082/kjfm.2013.34.5.319 Survey of Potentially Inappropriate Prescription Using STOPP/START Criteria in Inha University Hospital Original Article Sang-Jin

More information

A Geriatrician s Perspective on Successful Aging. Ariel Green, MD, MPH Assistant Professor of Medicine

A Geriatrician s Perspective on Successful Aging. Ariel Green, MD, MPH Assistant Professor of Medicine A Geriatrician s Perspective on Successful Aging Ariel Green, MD, MPH Assistant Professor of Medicine 1 Disclosures Johns Hopkins Clinical Research Scholars Program American College of Cardiology Foundation

More information

Measure #238 (NQF 0022): Use of High-Risk Medications in the Elderly National Quality Strategy Domain: Patient Safety

Measure #238 (NQF 0022): Use of High-Risk Medications in the Elderly National Quality Strategy Domain: Patient Safety Measure #238 (NQF 0022): Use of High-Risk Medications in the Elderly National Quality Strategy Domain: Patient Safety 2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE TYPE: Process DESCRIPTION:

More information

Bugs, Drugs and In the News: Recently Approved Drugs ANNESHA WHITE, PHARMD, MS, PHD UNIVERSITY OF NORTH TEXAS SYSTEM COLLEGE OF PHARMACY

Bugs, Drugs and In the News: Recently Approved Drugs ANNESHA WHITE, PHARMD, MS, PHD UNIVERSITY OF NORTH TEXAS SYSTEM COLLEGE OF PHARMACY Bugs, Drugs and In the News: Recently Approved Drugs ANNESHA WHITE, PHARMD, MS, PHD UNIVERSITY OF NORTH TEXAS SYSTEM COLLEGE OF PHARMACY New FDA-Approved Drugs Since January 2015, the FDA has approved

More information

Measure #238 (NQF 0022): Use of High-Risk Medications in the Elderly National Quality Strategy Domain: Patient Safety

Measure #238 (NQF 0022): Use of High-Risk Medications in the Elderly National Quality Strategy Domain: Patient Safety Measure #238 (NQF 0022): Use of High-Risk Medications in the Elderly National Quality Strategy Domain: Patient Safety 2015 PHYSICIAN QUALITY REPTING OPTIONS F INDIVIDUAL MEASURES REGISTRY ONLY DESCRIPTION:

More information

Prescribing and Pharmacokinetic Considerations in the Elderly

Prescribing and Pharmacokinetic Considerations in the Elderly Prescribing and Pharmacokinetic Considerations in the Elderly Melanie A. Dodd, Pharm.D., Ph.C., BCPS Associate Professor of Pharmacy in Geriatrics College of Pharmacy The University of New Mexico OBJECTIVES

More information

What are you trying to achieve? Falls Prevention, Assessment and Management Strategies. Falls can be classified into four main groups:

What are you trying to achieve? Falls Prevention, Assessment and Management Strategies. Falls can be classified into four main groups: What are you trying to achieve? Falls Prevention, Assessment and Management Strategies Dr Adam Darowski Community: Falls risk assessment: Falls risk is 50% per year in 80yr population and higher in those

More information

Application for Endorsement of CQI (Clinical Audit) Activities for MOPS Credits Allocation

Application for Endorsement of CQI (Clinical Audit) Activities for MOPS Credits Allocation Application for Endorsement of CQI (Clinical Audit) Activities for MOPS Credits Allocation Below is the form you need to fill out. NAME Dianne Vicary Health Hawke s Bay DATE JUNE 2012 TITLE OF ACTIVITY

More information

Use caution in the elderly: review of safe and effective medication use in older patients

Use caution in the elderly: review of safe and effective medication use in older patients Use caution in the elderly: review of safe and effective medication use in older patients John T. Holmes, PharmD, BCPS Assistant Professor of Family Medicine and Pharmacy Practice In support of improving

More information

Disclosures. Outline. Epidemiology. Medication Management in the Elderly. In 2008 pts age 65 and older represented 40% of all hospitalized adults

Disclosures. Outline. Epidemiology. Medication Management in the Elderly. In 2008 pts age 65 and older represented 40% of all hospitalized adults Medication Management in the Elderly Disclosures Melissa Stevens MD Atlanta VA Medical Center Assistant Professor Emory University Department of Medicine I have no significant financial interest or other

More information

Potentially Harmful Drugs in the Elderly: Beers List

Potentially Harmful Drugs in the Elderly: Beers List PL Detail-Document #311201 This PL Detail-Document gives subscribers additional insight related to the Recommendations published in PHARMACIST S LETTER / PRESCRIBER S LETTER December 2015 Potentially Harmful

More information

ESSENTIAL CARE AFTER AN IN-PATIENT FALL

ESSENTIAL CARE AFTER AN IN-PATIENT FALL ESSENTIAL CARE AFTER AN IN-PATIENT FALL In line with the National Patient Safety Agency Rapid Response Report (NPSA/2011/RRR001): Essential care after an inpatient fall, in caring for a patient who has

More information

The Geriatric Assessment. Dr. Gary Mumaugh Western Physical Assessment

The Geriatric Assessment. Dr. Gary Mumaugh Western Physical Assessment The Geriatric Assessment Dr. Gary Mumaugh Western Physical Assessment Geriatric Assessment The number of elderly Americans older than 65 yrs of age could increase from 34 million in 1998 to approximately

More information

POLYPHARMACY in the ELDERLY. C. Frank Webber Lectureship Dale C. Moquist, MD April 13, 2018

POLYPHARMACY in the ELDERLY. C. Frank Webber Lectureship Dale C. Moquist, MD April 13, 2018 POLYPHARMACY in the ELDERLY C. Frank Webber Lectureship Dale C. Moquist, MD April 13, 2018 1 Speaker Disclosure Dr. Moquist has disclosed that he has no actual or potential conflict of interest in relation

More information

Safe Prescribing in Dementia

Safe Prescribing in Dementia Safe Prescribing in Dementia Dr Daniel Harwood Consultant Psychiatrist and Clinical Director, London Strategic Clinical Network Gurdeep Kaur Major Rapid Access Team Senior Pharmacist, Camden CNWL NHS Trust

More information

CONTRAINDICATIONS TABLE

CONTRAINDICATIONS TABLE CONTRAINDICATIONS TABLE Generic Name Brand Name Contraindications Amphetamine Salts Adderall, Adderall XR Hypersensitivity to amphetamine, dextroamphetamine, or other sympathomimetic amines Advanced arteriosclerosis

More information

Measure #238 (NQF 0022): Use of High-Risk Medications in the Elderly National Quality Strategy Domain: Patient Safety

Measure #238 (NQF 0022): Use of High-Risk Medications in the Elderly National Quality Strategy Domain: Patient Safety Measure #238 (NQF 0022): Use of High-Risk Medications in the Elderly National Quality Strategy Domain: Patient Safety 2016 PHYSICIAN QUALITY REPORTING OPTIONS FOR INDIVIDUAL MEASURES REGISTRY ONLY DESCRIPTION:

More information

Prescribing Drugs to the Elderly

Prescribing Drugs to the Elderly Answers to your questions from University of Toronto experts Prescribing Drugs to the Elderly Can drugs do more harm than good? M.A. is a 90-year-old man living at home. He has dementia and due to wandering

More information

HTN talk_l Davis_ /28/2018

HTN talk_l Davis_ /28/2018 1 2 GUIDELINES PUBLISHED AHEAD OF PRINT NOV 13, 2017 = SAME DAY AS PUBLIC PRESENTATION LESLIE L DAVIS, PHD, RN, ANP-BC, FPCNA, FAANP, FAHA The New Guidelines Have Been Published! Whelton PK, Carey RM,

More information

There s A Pill For That (But should my patient be on it?) A Review of Tools for the Evaluation of Optimal Prescribing in Geriatric Patients

There s A Pill For That (But should my patient be on it?) A Review of Tools for the Evaluation of Optimal Prescribing in Geriatric Patients There s A Pill For That (But should my patient be on it?) A Review of Tools for the Evaluation of Optimal Prescribing in Geriatric Patients Marilyn N. Bulloch, PharmD, BCPS Assistant Clinical Professor

More information

SUMMARY OF ARIZONA OPIOID PRESCRIBING GUIDELINES FOR THE TREATMENT OF CHRONIC NON-TERMINAL PAIN (CNTP)

SUMMARY OF ARIZONA OPIOID PRESCRIBING GUIDELINES FOR THE TREATMENT OF CHRONIC NON-TERMINAL PAIN (CNTP) 9 SUMMARY OF ARIZONA OPIOID PRESCRIBING GUIDELINES FOR THE TREATMENT OF CHRONIC NON-TERMINAL PAIN (CNTP) SUMMARY OF ARIZONA OPIOID PRESCRIBING GUIDELINES FOR THE TREATMENT OF ACUTE PAIN NONOPIOID TREATMENTS

More information

Pain Management in a Geriatric Population. Alan Obringer RPh, CPh, CGP Executive Director Senior Care Pharmacy of Florida

Pain Management in a Geriatric Population. Alan Obringer RPh, CPh, CGP Executive Director Senior Care Pharmacy of Florida Pain Management in a Geriatric Population Alan Obringer RPh, CPh, CGP Executive Director Senior Care Pharmacy of Florida Objectives Review definitions and types of pain Discuss purpose and value of pain

More information

If a bad thing is happening to a patient, a drug did it until proven otherwise

If a bad thing is happening to a patient, a drug did it until proven otherwise Dr Vicki s First Rule of Geriatrics Deprescribing in the Elderly Victoria Braund MD, FACP, CMD Director, Division of Geriatrics NorthShore University HealthSystem Medical Director, Brandel Health & Rehab

More information

GI Pharmacology -4 Irritable Bowel Syndrome and Antiemetics. Dr. Alia Shatanawi

GI Pharmacology -4 Irritable Bowel Syndrome and Antiemetics. Dr. Alia Shatanawi GI Pharmacology -4 Irritable Bowel Syndrome and Antiemetics Dr. Alia Shatanawi 11-04-2018 Drugs used in Irritable Bowel Syndrome Idiopathic, chronic, relapsing disorder characterized by abdominal discomfort

More information

Rational prescribing in the older adult. Assoc Prof Craig Whitehead

Rational prescribing in the older adult. Assoc Prof Craig Whitehead Rational prescribing in the older adult Assoc Prof Craig Whitehead Introduction Physioloical ageing and frailty Medication risks in older adults Drug Burden Anticholinergic and sedative drug burden Cascade

More information

Session ID: 1005 June 15, Older Adults. Director of Clinical and Educational Programs Peter Lamy Center on Drug Therapy and Aging

Session ID: 1005 June 15, Older Adults. Director of Clinical and Educational Programs Peter Lamy Center on Drug Therapy and Aging Mdi Medication Misadventures in Older Adults Nicole Brandt, PharmD, CGP, BCPP, FASCP Director of Clinical and Educational Programs Peter Lamy Center on Drug Therapy and Aging AssociateProfessor Professor,

More information

Management of Delirium in Hospice Patients

Management of Delirium in Hospice Patients Presentation Objectives Management of Delirium in Hospice Patients Lynn Williams, BSPharm Clinical Pharmacist Hospice Pharmacy Solutions Identify the clinical features of delirium Understand the underlying

More information

Psychotropic Medication Use in Dementia

Psychotropic Medication Use in Dementia Psychotropic Medication Use in Dementia Marie A DeWitt, MD Diplomate of the American Board of Psychiatry and Neurology, Specialization in Psychiatry & Subspecialization in Geriatric Psychiatry Staff Physician,

More information

SenioRx Care Perspective

SenioRx Care Perspective CT-ASCP's SenioRx Care Perspective Spring 2016 Volume III No. 1 Inside: Out with the Old, In with the New 2015 AGS Beers Criteria Update Pages 2-4 Save the Date! Schwarting Senior Symposium Page 5 3rd

More information